EUVIMEDEUVIMED entdecken
Leitlinie

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026

Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, Haris Ali, Mariana Castells, Brian J Chernak, Manuel R Espinoza-Gutarra, Ruth Fein Revell, Steven Green, Krishna Gundabolu, Elizabeth Hexner, Tania Jain und 21 weitere

Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)

DOI: 10.6004/jnccn.2026.0034 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-07. Verfasst von Aaron T Gerds und 32 weiteren Autor:innen. Beteiligte Einrichtung: 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute. Hauptthemen laut MEDLINE: Myeloproliferative Disorders. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are a group of heterogenous hematologic malignancies characterized by the proliferation of blood cells and consist of myelofibrosis, polycythemia vera, and essential thrombocythemia. The NCCN Guidelines for MPN were developed as a result of meetings convened by a multidisciplinary panel with expertise in MPN, with the aim of providing recommendations for the comprehensive care of adults with these diseases. The panel of experts convenes at least once a year to discuss requested changes to the Guidelines and to evaluate emerging data. These Guideline Insights focus on some of the recent updates for myelofibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersHumansPrimary Myelofibrosis

Autor:innen und Institutionen

  • 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • 2Stanford Cancer Institute.
  • 3Fox Chase Cancer Center.
  • 4City of Hope National Medical Center.
  • 5Dana-Farber/Brigham and Women's Cancer Center.
  • 6Memorial Sloan Kettering Cancer Center.

Zitieren

APA

Gerds, A. T., Gotlib, J., Abdelmessieh, P., Ali, H., Castells, M., Chernak, B. J., Espinoza-Gutarra, M. R., Fein Revell, R., Green, S., Gundabolu, K., Hexner, E., Jain, T., Jamieson, C. H., Khan, I., Kuykendall, A. T., Madanat, Y. F., Masarova, L., McMahon, B., Mohan, S. R., …, & Hochstetler, C. (2026). NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026. Journal of the National Comprehensive Cancer Network, 24(7). https://doi.org/10.6004/jnccn.2026.0034

Vancouver

Gerds AT, Gotlib J, Abdelmessieh P, Ali H, Castells M, Chernak BJ, et al. NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026. Journal of the National Comprehensive Cancer Network. 2026;24(7). doi:10.6004/jnccn.2026.0034

BibTeX
@article{Gerds2026,
  author = {Gerds, Aaron T and Gotlib, Jason and Abdelmessieh, Peter and Ali, Haris and Castells, Mariana and Chernak, Brian J and Espinoza-Gutarra, Manuel R and Fein Revell, Ruth and Green, Steven and Gundabolu, Krishna and Hexner, Elizabeth and Jain, Tania and Jamieson, Catriona H and Khan, Irum and Kuykendall, Andrew T and Madanat, Yazan F and Masarova, Lucia and McMahon, Brandon and Mohan, Sanjay R and Nadiminti, Kalyan V and Oh, Stephen and Palmer, Jeanne and Patel, Ami B and Patel, Anand A and Podoltsev, Nikolai and Rein, Lindsay and Salit, Rachel and Sehl, Mary and Talpaz, Moshe and Wadleigh, Martha and Wall, Sarah A and Bergman, Mary Anne and Hochstetler, Cindy},
  title = {NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {7},
  doi = {10.6004/jnccn.2026.0034}
}
Kostenlos starten →